Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials | Cerebrovascular Disease | JAMA Neurology | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Jauch  EC, Saver  JL, Adams  HP  Jr,  et al; American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology.  Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.  Stroke. 2013;44(3):870-947.PubMedGoogle ScholarCrossref
Collins  F. Clot removal: impressive results for stent retrievers in acute stroke. 2015. Accessed July 1, 2015.
Berkhemer  OA, Fransen  PS, Beumer  D,  et al; MR CLEAN Investigators.  A randomized trial of intraarterial treatment for acute ischemic stroke.  N Engl J Med. 2015;372(1):11-20.PubMedGoogle ScholarCrossref
Campbell  BC, Mitchell  PJ, Kleinig  TJ,  et al; EXTEND-IA Investigators.  Endovascular therapy for ischemic stroke with perfusion-imaging selection.  N Engl J Med. 2015;372(11):1009-1018.PubMedGoogle ScholarCrossref
Goyal  M, Demchuk  AM, Menon  BK,  et al; ESCAPE Trial Investigators.  Randomized assessment of rapid endovascular treatment of ischemic stroke.  N Engl J Med. 2015;372(11):1019-1030.PubMedGoogle ScholarCrossref
Jovin  TG, Chamorro  A, Cobo  E,  et al; REVASCAT Trial Investigators.  Thrombectomy within 8 hours after symptom onset in ischemic stroke.  N Engl J Med. 2015;372(24):2296-2306.PubMedGoogle ScholarCrossref
Saver  JL, Goyal  M, Bonafe  A,  et al; SWIFT PRIME Investigators.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke.  N Engl J Med. 2015;372(24):2285-2295.PubMedGoogle ScholarCrossref
Moher  D, Liberati  A, Tetzlaff  J, Altman  DG; PRISMA Group.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.  PLoS Med. 2009;6(7):e1000097.PubMedGoogle ScholarCrossref
Wilczynski  NL, McKibbon  KA, Haynes  RB.  Enhancing retrieval of best evidence for health care from bibliographic databases: calibration of the hand search of the literature.  Stud Health Technol Inform. 2001;84(pt 1):390-393.PubMedGoogle Scholar
Goldstein  LB, Bertels  C, Davis  JN.  Interrater reliability of the NIH stroke scale.  Arch Neurol. 1989;46(6):660-662.PubMedGoogle ScholarCrossref
Farrell  B, Godwin  J, Richards  S, Warlow  C.  The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.  J Neurol Neurosurg Psychiatry. 1991;54(12):1044-1054.PubMedGoogle ScholarCrossref
Higgins  JP, Altman  DG, Gøtzsche  PC,  et al; Cochrane Bias Methods Group; Cochrane Statistical Methods Group.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.  BMJ. 2011;343:d5928.PubMedGoogle ScholarCrossref
Mahoney  FI, Barthel  DW.  Functional evaluation: the Barthel Index.  Md State Med J. 1965;14:61-65.PubMedGoogle Scholar
Hughes S. Medscape Medical News: Conference News. THRACE: Seventh Endovascular Trial Shows Benefit in Stroke. April 20, 2015. Accessed: September 22, 2015.
Gory  B, Eldesouky  I, Sivan-Hoffmann  R,  et al.  Outcomes of stent retriever thrombectomy in basilar artery occlusion: an observational study and systematic review [published online May 18, 2015].  J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2014-310250.PubMedGoogle Scholar
Grech  R, Mizzi  A, Pullicino  R, Thornton  J, Downer  J.  Functional outcomes and recanalization rates of stent retrievers in acute ischaemic stroke: a systematic review and meta-analysis.  Neuroradiol J. 2015;28(2):152-171.PubMedGoogle ScholarCrossref
Puñal-Riobóo  J, Atienza  G, Blanco  M.  Safety and efficacy of mechanical thrombectomy using stent retrievers in the endovascular treatment of acute ischaemic stroke: a systematic review.  Interv Neurol. 2015;3(3-4):149-164.PubMedGoogle ScholarCrossref
Goyal  M, Menon  BK.  Variability of results of recent acute endovascular trials: a statistical analysis [published online August 5, 2015].  J Neurointerv Surg. doi:10.1136/neurintsurg-2015-011962.PubMedGoogle Scholar
Chen  CJ, Ding  D, Starke  RM,  et al.  Endovascular vs medical management of acute ischemic stroke.  Neurology. 2015;85(22):1980-1990.PubMedGoogle ScholarCrossref
Fargen  KM, Neal  D, Fiorella  DJ, Turk  AS, Froehler  M, Mocco  J.  A meta-analysis of prospective randomized controlled trials evaluating endovascular therapies for acute ischemic stroke.  J Neurointerv Surg. 2015;7(2):84-89.PubMedGoogle ScholarCrossref
Hong  KS, Ko  SB, Lee  JS, Yu  KH, Rha  JH.  Endovascular recanalization therapy in acute ischemic stroke: updated meta-analysis of randomized controlled trials.  J Stroke. 2015;17(3):268-281.PubMedGoogle ScholarCrossref
Mocco  J, Fiorella  D, Fargen  KM,  et al.  Endovascular therapy for acute ischemic stroke is indicated and evidence based: a position statement.  J Neurointerv Surg. 2015;7(2):79-81.PubMedGoogle ScholarCrossref
Powers  WJ, Derdeyn  CP, Biller  J,  et al; American Heart Association Stroke Council.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.  Stroke. 2015;46(10):3020-3035.PubMedGoogle ScholarCrossref
Ioannidis  JP.  Why most discovered true associations are inflated.  Epidemiology. 2008;19(5):640-648.PubMedGoogle ScholarCrossref
Original Investigation
March 2016

Stent Retrievers for the Treatment of Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Author Affiliations
  • 1Division of Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital/McGill University, Montreal, Quebec, Canada
  • 2Faculty of Medicine, McGill University, Montreal, Quebec, Canada
  • 3Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
  • 4Division of Cardiology, Jewish General Hospital/McGill University, Montreal, Quebec, Canada
JAMA Neurol. 2016;73(3):275-281. doi:10.1001/jamaneurol.2015.4441

Importance  Stent retrievers are a promising alternative for the treatment of acute ischemic stroke (AIS). Several recently completed clinical trials have examined the use of stent retrievers with intravenous recombinant tissue plasminogen activator (rtPA) compared with rtPA alone.

Objective  To conduct a systematic review and meta-analysis of randomized clinical trials to quantify the benefits and risks of using stent retrievers in addition to rtPA for the treatment of AIS.

Data Sources  The MEDLINE, EMBASE, and Cochrane Library of Clinical Trials databases were searched from inception to July 2015 for the keywords stent*, retriev*, Solitaire, Trevo, Revive, and stroke. Trial registries were also searched. A total of 326 publications were identified and 213 potentially relevant records were screened.

Study Selection  Randomized clinical trials that examined stent retrievers with rtPA vs rtPA alone were included in the meta-analysis.

Data Extraction and Synthesis  Two independent reviewers extracted study data and performed quality assessment using the Cochrane Risk of Bias Tool. DerSimonian and Laird random-effects models were used to estimate relative risks (RRs), risk differences (RDs), and numbers needed to treat.

Main Outcomes and Measures  The primary outcome was the proportion of patients achieving functional independence (defined as a score of 0-2 on the modified Rankin Scale, with 0 indicating no disability and 6 indicating death) at 90 days. Risks of all-cause mortality, intracranial hemorrhage, and parenchymal hematoma at 90 days were also assessed.

Results  Five randomized clinical trials met our inclusion criteria (n = 1287 patients). Patients randomized to stent-retriever therapy with rtPA had significantly improved rates of functional independence at 90 days compared with those randomized to rtPA alone (RR, 1.72; 95% CI, 1.48-1.99; RD, 0.19; 95% CI, 0.13-0.25). When data were pooled across trials, the effect of stent-retriever therapy on all-cause mortality at 90 days was inconclusive (RR, 0.82; 95% CI, 0.60-1.11; RD, −0.04; 95% CI, −0.08 to 0.1). There were similarly no detectable differences in the risks of intracranial hemorrhage (RR, 1.15; 95% CI, 0.67-1.97; RD, 0.00; 95% CI, −0.02 to 0.03) or parenchymal hematoma (RR, 1.18; 95% CI, 0.71-1.94; RD, 0.01; 95% CI, −0.01 to 0.04), although the 95% CIs were wide. Fixed-effects sensitivity analyses produced similar results for all outcomes.

Conclusions and Relevance  The use of stent retrievers in conjunction with rtPA vs rtPA alone is associated with significant improvement of functional independence 90 days after AIS.